Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,913 | 9,478 | 2,473 | 4,733 | 5,561 |
| Other current assets | 0 | 0 | 0 | 71 | 0 |
| TOTAL | $4,181 | $9,698 | $2,768 | $5,131 | $5,816 |
| Non-Current Assets | |||||
| PPE Net | 1,729 | 2,034 | 2,361 | 2,645 | 3,045 |
| Intangibles | 1,676 | 1,676 | 1,676 | 1,676 | 1,676 |
| Other Non-Current Assets | 12 | 12 | 12 | 2,027 | 27 |
| TOTAL | $3,416 | $3,721 | $4,048 | $6,348 | $4,747 |
| Total Assets | $7,596 | $13,420 | $6,816 | $11,478 | $10,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 676 | 934 | 1,162 | 717 | 478 |
| Other current liabilities | 4,781 | 5,177 | 3,359 | 13 | 23 |
| TOTAL | $5,703 | $6,233 | $4,523 | $733 | $504 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 236 | 478 | 593 | 585 | 574 |
| TOTAL | $244 | $489 | $593 | $587 | $579 |
| Total Liabilities | $5,947 | $6,722 | $5,116 | $1,320 | $1,082 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 0 | 0 | 57,398 | 57,398 | 36,908 |
| Common Shares | N/A | 0 | 0 | 1 | 0 |
| Retained earnings | -64,607 | -59,112 | -51,060 | -40,277 | -31,480 |
| TOTAL | $1,650 | $6,698 | $1,700 | $10,158 | $9,481 |
| Total Liabilities And Equity | $7,596 | $13,420 | $6,816 | $11,478 | $10,563 |